speb/financial-data huggingface dataset:
Financial ratios for GZF.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 13854166666.666668
Buffett classification: The Gruesome
Stock price: 13.895833333333334
Shares outstanding: 2540925616
Book value: 43185416666.66669
P/B ratio: 0.8175972723585311
Market cap (USD): 35308278872.333336
Debt to equity: 1.2544502870374832
Current ratio: 1.088839800230503
Quick ratio: 1.0194006915097962
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GZF.DE — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 11615294117.647058
Buffett classification: The Gruesome
Stock price: 22.341176470588234
Shares outstanding: 2540925616
Book value: 45083529411.76471
P/B ratio: 1.2591575754244408
Market cap (USD): 56767267585.694115
Debt to equity: 1.3622034915581533
Current ratio: 1.0593352829737535
Quick ratio: 1.001177141385716
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HRMY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 42.64
Shares outstanding: 57892676
Market cap (USD): 2468543704.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HRMY — annual report dated 2022-12-31
Total revenue: 437855000
Gross profit: 354374000
Operating income: 120186000
Net income: 181468000
Capital expenditures: 172000
Operating cash flow: 144466000
Depreciation & amortization: 23385000
Net tangible assets: 241885000
Owner earnings: 204681000
Return on net tangible assets (%): 84.61913719329434
Capex to operating income (%): 0.14311151049207063
Buffett classification: The Great
Stock price: 55.1
P/E ratio: 17.578231134965947
Shares outstanding: 57892676
Book value: 402838000
P/B ratio: 7.918534119422696
Market cap (USD): 3189886447.6
Debt to equity: 0.4757421097314553
Current ratio: 5.074349678008215
Quick ratio: 5.019877288169971
Effective tax rate (%): -73.34505091416236
Interest coverage ratio: 6.394573024740622
COGS to revenue (%): 19.06590081191262
R&D to revenue (%): 16.18937776204451
SG&A to revenue (%): 37.29590846284729
Free cash flow (dilution-adjusted): 118121000
Buyback yield (%): 0
Retained earnings: -272130000
Inventory turnover: 19.427740283919015
Receivables turnover: 7.998812568505663
Capitalized R&D asset: 70886000
ROCI (R&D-adjusted, %): 25.146474597720488
FCF margin (%): 26.97719564696075
Rule of 40 score: 26.97719564696075
Financial ratios for HRMY — annual report dated 2023-12-31
Total revenue: 582022000
Gross profit: 460786000
Operating income: 192030000
Net income: 128853000
Capital expenditures: 312000
Operating cash flow: 219387000
Depreciation & amortization: 24359000
Net tangible assets: 329884000
Owner earnings: 152900000
Return on net tangible assets (%): 46.349625929114474
Capex to operating income (%): 0.16247461334166535
Buffett classification: The Great
Stock price: 32.3
P/E ratio: 14.512145117304215
Shares outstanding: 57892676
Book value: 466992000
P/B ratio: 4.004208711926542
Market cap (USD): 1869933434.8
Debt to equity: 0.41449532326035565
Current ratio: 2.7541045664637536
Quick ratio: 2.721359620468797
Effective tax rate (%): 25.688597199474035
Interest coverage ratio: 8.08309129940649
COGS to revenue (%): 20.83014044142661
R&D to revenue (%): 13.068749978523147
SG&A to revenue (%): 33.10751139991272
Free cash flow (dilution-adjusted): 187370000
Buyback yield (%): 5.34778394454964
Retained earnings: -143277000
Inventory turnover: 22.606004102181615
Receivables turnover: 7.8503102239007285
Capitalized R&D asset: 123556620
ROCI (R&D-adjusted, %): 28.41069623878999
Rosenberg metric: 1.5011708941116724
FCF margin (%): 32.19294116029978
Revenue growth (%): 32.9257402564776
Rule of 40 score: 65.11868141677738
Financial ratios for HRMY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 40
Shares outstanding: 57892676
Market cap (USD): 2315707040
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HRMY — annual report dated 2024-12-31
Total revenue: 714734000
Gross profit: 557919000
Operating income: 190826000
Net income: 145493000
Capital expenditures: 1153000
Operating cash flow: 219821000
Depreciation & amortization: 24112000
Net tangible assets: 545892000
Owner earnings: 168452000
Return on net tangible assets (%): 30.858118455665224
Capex to operating income (%): 0.6042153584941256
Buffett classification: The Great
Stock price: 34.41
P/E ratio: 13.691978178743994
Shares outstanding: 57892676
Book value: 659155000
P/B ratio: 3.022182917765927
Market cap (USD): 1992086981.1599998
Debt to equity: 0.27196334701246294
Current ratio: 3.3084611781907904
Quick ratio: 3.267349013605054
Effective tax rate (%): 24.1449604804905
Interest coverage ratio: 10.906835848193873
COGS to revenue (%): 21.940330248735894
R&D to revenue (%): 20.402695268449524
SG&A to revenue (%): 30.958090702275253
Free cash flow (dilution-adjusted): 176066000
Buyback yield (%): 0
Retained earnings: 2216000
Inventory turnover: 21.78591275354265
Receivables turnover: 8.607830621560103
Capitalized R&D asset: 220179590
ROCI (R&D-adjusted, %): 22.89191021370323
Rosenberg metric: 1.2770072177011162
FCF margin (%): 24.63377983977256
Revenue growth (%): 22.801887213885387
Rule of 40 score: 47.43566705365795
Financial ratios for HRMY — quarterly report dated 2024-12-31
Capital expenditures: 513000
Buffett classification: The Gruesome
Stock price: 34.41
Shares outstanding: 57892676
Market cap (USD): 1992086981.1599998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HRMY — quarterly report dated 2025-03-31
Total revenue: 184733000
Gross profit: 152739000
Operating income: 56245000
Net income: 45560000
Capital expenditures: 128000
Operating cash flow: 33987000
Depreciation & amortization: 5968000
Net tangible assets: 613223000
Owner earnings: 51400000
Return on net tangible assets (%): 8.381942621199792
Capex to operating income (%): 0.22757578451417906
Buffett classification: The Great
Stock price: 33.19
P/E ratio: 10.543557487050045
Shares outstanding: 57892676
Book value: 720525000
P/B ratio: 2.6667470475556017
Market cap (USD): 1921457916.4399998
Debt to equity: 0.24382498872350022
Current ratio: 3.6700510512911295
Quick ratio: 3.633595632659121
Effective tax rate (%): 20.317610227888835
Interest coverage ratio: 14.662408759124087
COGS to revenue (%): 17.319049655448673
R&D to revenue (%): 18.69725495715438
SG&A to revenue (%): 33.53705077057158
Free cash flow (dilution-adjusted): 21360000
Buyback yield (%): 0
Retained earnings: 47776000
Inventory turnover: 5.011591478696742
Receivables turnover: 1.7432739763515746
Capitalized R&D asset: 34540000
ROCI (R&D-adjusted, %): 8.66397728709291
FCF margin (%): 11.562633638819268
Rule of 40 score: 11.562633638819268
Financial ratios for HRMY — quarterly report dated 2025-06-30
Total revenue: 200489000
Gross profit: 162336000
Operating income: 48180000
Net income: 39776000
Capital expenditures: 4000
Operating cash flow: 79327000
Depreciation & amortization: 5967000
Net tangible assets: 671739000
Owner earnings: 45739000
Return on net tangible assets (%): 6.80904339334176
Capex to operating income (%): 0.008302200083022002
Buffett classification: The Great
Stock price: 31.6
P/E ratio: 21.437711652760854
Shares outstanding: 57892676
Book value: 773080000
P/B ratio: 2.366389715941429
Market cap (USD): 1829408561.6000001
Debt to equity: 0.22260956175298804
Current ratio: 3.8379770727509923
Quick ratio: 3.8041135814805562
Effective tax rate (%): 19.866228821242217
Interest coverage ratio: 13.214481623697202
COGS to revenue (%): 19.029971719146687
R&D to revenue (%): 25.01833018270329
SG&A to revenue (%): 31.920454488774947
Free cash flow (dilution-adjusted): 67868000
Buyback yield (%): 0
Retained earnings: 87552000
Inventory turnover: 6.254590163934426
Receivables turnover: 2.1562362203030725
Capitalized R&D asset: 73300800
ROCI (R&D-adjusted, %): 7.002380605645094
Rosenberg metric: 0.27785176606832657
FCF margin (%): 33.85123373352154
Revenue growth (%): 8.529066274027922
Rule of 40 score: 42.380300007549465
Financial ratios for HRMY — quarterly report dated 2025-09-30
Total revenue: 239455000
Gross profit: 179805000
Operating income: 65487000
Net income: 50865000
Capital expenditures: 71000
Operating cash flow: 108734000
Depreciation & amortization: 5968000
Net tangible assets: 739743000
Owner earnings: 56762000
Return on net tangible assets (%): 7.673205424045919
Capex to operating income (%): 0.10841846473345854
Buffett classification: The Great
Stock price: 27.56
P/E ratio: 11.714467225350768
Shares outstanding: 57892676
Book value: 835123000
P/B ratio: 1.9105235403168155
Market cap (USD): 1595522150.56
Debt to equity: 0.20177387043585196
Current ratio: 3.754649668983854
Quick ratio: 3.723844353030174
Effective tax rate (%): 24.63327900429693
Interest coverage ratio: 18.08533554266777
COGS to revenue (%): 24.910734793593786
R&D to revenue (%): 22.952955670167672
SG&A to revenue (%): 24.78795598337892
Free cash flow (dilution-adjusted): 97694000
Buyback yield (%): 0
Retained earnings: 138417000
Inventory turnover: 8.667538506248183
Receivables turnover: 2.3790623043983667
Capitalized R&D asset: 99966730
ROCI (R&D-adjusted, %): 6.812000173835278
Rosenberg metric: 0.348272493470763
FCF margin (%): 40.798479881397334
Revenue growth (%): 19.435480250786828
Rule of 40 score: 60.233960132184166
Financial ratios for HRMY — annual report dated 2025-12-31
Total revenue: 868453000
Gross profit: 670111000
Operating income: 208469000
Net income: 158687000
Capital expenditures: 310000
Operating cash flow: 348199000
Depreciation & amortization: 25335000
Net tangible assets: 780800000
Owner earnings: 183712000
Return on net tangible assets (%): 23.528688524590162
Capex to operating income (%): 0.14870316449927806
Buffett classification: The Great
Stock price: 37.42
P/E ratio: 13.651678687731195
Shares outstanding: 57892676
Book value: 870218000
P/B ratio: 2.489426713674045
Market cap (USD): 2166343935.92
Debt to equity: 0.1880712649014385
Current ratio: 3.597377564133073
Quick ratio: 3.5761307569051133
Effective tax rate (%): 26.214057210876764
Interest coverage ratio: 14.230937265342344
COGS to revenue (%): 22.838541636680397
R&D to revenue (%): 21.83123323887418
SG&A to revenue (%): 31.32558699204217
Free cash flow (dilution-adjusted): 302994000
Buyback yield (%): 0
Retained earnings: 160903000
Inventory turnover: 37.02482732872877
Receivables turnover: 8.972826929236364
Capitalized R&D asset: 312397540
ROCI (R&D-adjusted, %): 19.58878377545251
Rosenberg metric: 0.7693605348877078
FCF margin (%): 34.8889346919177
Revenue growth (%): 21.507162105062864
Rule of 40 score: 56.39609679698056
Financial ratios for HRMY — quarterly report dated 2025-12-31
Total revenue: 243776000
Gross profit: 175231000
Operating income: 38557000
Net income: 22486000
Capital expenditures: 107000
Operating cash flow: 126151000
Depreciation & amortization: 7432000
Net tangible assets: 780800000
Owner earnings: 29811000
Return on net tangible assets (%): 3.8180071721311477
Capex to operating income (%): 0.27751121715901134
Buffett classification: The Great
Stock price: 37.42
P/E ratio: 13.651678687731195
Shares outstanding: 57892676
Book value: 870218000
P/B ratio: 2.489426713674045
Market cap (USD): 2166343935.92
Debt to equity: 0.1880712649014385
Current ratio: 3.597377564133073
Quick ratio: 3.5761307569051133
Effective tax rate (%): 44.833169774288514
Interest coverage ratio: 10.873378454596729
COGS to revenue (%): 28.11802638487792
R&D to revenue (%): 20.483148464163822
SG&A to revenue (%): 35.58225584142819
Free cash flow (dilution-adjusted): 116072000
Buyback yield (%): 0
Retained earnings: 160903000
Inventory turnover: 12.7954078775434
Receivables turnover: 2.5186853606372757
Capitalized R&D asset: 103310010
ROCI (R&D-adjusted, %): 3.277969183141248
Rosenberg metric: -0.08322113460208871
FCF margin (%): 47.6142032029404
Revenue growth (%): 1.8045144181579
Rule of 40 score: 49.4187176210983
Financial ratios for ICRA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.78821047078993
Shares outstanding: 9625105
Market cap (USD): 508092068.5434525
Buyback yield (%): 0
Retained earnings: 95023354.87274165
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICRA.NS — annual report dated 2023-03-31
Total revenue: 48793788.06333739
Gross profit: 25591546.89403167
Operating income: 16243495.736906214
Net income: 16653507.91717418
Capital expenditures: 1077965.8952496955
Operating cash flow: 12089902.557856273
Depreciation & amortization: 1197210.71863581
Net tangible assets: 114708014.61632156
Owner earnings: 16772752.740560293
Return on net tangible assets (%): 14.622128014910071
Capex to operating income (%): 6.636292536467327
Buffett classification: The Great
Stock price: 51.28440925700365
P/E ratio: 29.64047132992211
Shares outstanding: 9625105
Book value: 116312813.64190012
P/B ratio: 4.243881722966187
Market cap (USD): 493617823.96163213
Debt to equity: 0.01364343413462918
Current ratio: 4.291974869615446
Quick ratio: 4.291974869615446
Effective tax rate (%): 24.551781451450026
Interest coverage ratio: 94.4135221238938
COGS to revenue (%): 47.55162919342881
SG&A to revenue (%): 4.138248663869176
Free cash flow (dilution-adjusted): 10982911.08404385
Buyback yield (%): 0
Retained earnings: 100957831.91230208
Receivables turnover: 10.528699199171573
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.761527911396461
FCF margin (%): 22.508830570373718
Rule of 40 score: 22.508830570373718
Financial ratios for ICRA.NS — annual report dated 2024-03-31
Total revenue: 53271687.25266819
Gross profit: 25569648.63892553
Operating income: 16748327.137546469
Net income: 18256613.502818085
Capital expenditures: 817999.7601630891
Operating cash flow: 12832497.901427029
Depreciation & amortization: 1614630.0515649358
Net tangible assets: 110908514.21033697
Owner earnings: 19053243.794219933
Return on net tangible assets (%): 17.17924356833925
Capex to operating income (%): 4.88406844125521
Buffett classification: The Great
Stock price: 63.665187140115165
P/E ratio: 33.565048138509866
Shares outstanding: 9625105
Book value: 117637666.38685691
P/B ratio: 5.209080814754428
Market cap (USD): 612784111.0682582
Debt to equity: 0.012928493481776654
Current ratio: 4.322654543610801
Quick ratio: 4.322654543610801
Effective tax rate (%): 23.82580423716178
Interest coverage ratio: 13.418292741509344
COGS to revenue (%): 52.001428981123844
SG&A to revenue (%): 5.260149750378518
Free cash flow (dilution-adjusted): 11807171.12363593
Buyback yield (%): 0
Retained earnings: 102506655.4742775
Receivables turnover: 8.69511586438807
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.496941586308575
FCF margin (%): 22.16406450134457
Revenue growth (%): 9.177191128342404
Rule of 40 score: 31.341255629686973
Financial ratios for ICRA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 107733229.8136646
Buffett classification: The Gruesome
Stock price: 85.6808408982322
Shares outstanding: 9625105
Book value: 114603810.32011467
P/B ratio: 7.195983168711751
Market cap (USD): 824687090.1337793
Debt to equity: 0.015312417955416942
Current ratio: 3.9976858741236487
Quick ratio: 3.9976858741236487
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICRA.NS — quarterly report dated 2024-12-31
Total revenue: 14089334.421261217
Gross profit: 6556043.827951975
Operating income: 4425853.829117613
Net income: 4921424.408439212
Capital expenditures: 0
Depreciation & amortization: 488297.00431285694
Owner earnings: 5409721.412752069
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 73.77363329059331
P/E ratio: 36.070805305666156
Shares outstanding: 9625105
Market cap (USD): 710078966.6534561
Effective tax rate (%): 24.27192650479882
Interest coverage ratio: 35.492054589642926
COGS to revenue (%): 53.46803736833223
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ICRA.NS — quarterly report dated 2025-03-31
Total revenue: 15923883.563245265
Gross profit: 8776736.029927518
Operating income: 6392050.5026888
Net income: 6545440.729483282
Capital expenditures: 0
Depreciation & amortization: 524012.1580547112
Net tangible assets: 116965454.75800794
Owner earnings: 7069452.8875379935
Return on net tangible assets (%): 6.044051982838967
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 63.67125685610923
P/E ratio: 23.40722947660092
Shares outstanding: 9625105
Book value: 123643944.35351883
P/B ratio: 4.95651069630876
Market cap (USD): 612842532.7220212
Debt to equity: 0.012419511439650702
Current ratio: 6.360043401234054
Quick ratio: 6.360043401234054
Effective tax rate (%): 24.397192999512544
Interest coverage ratio: 43.970727784479294
COGS to revenue (%): 44.88319388251774
Buyback yield (%): 0
Retained earnings: 108554851.53144726
Receivables turnover: 2.7068690730745693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.897314446735471
Revenue growth (%): 13.020836095817693
Rule of 40 score: 13.020836095817693
Financial ratios for ICRA.NS — annual report dated 2025-03-31
Total revenue: 58101554.82815057
Gross profit: 28560848.72574234
Operating income: 18891243.862520456
Net income: 20014519.523030158
Capital expenditures: 1429646.9487958848
Operating cash flow: 16938543.371522095
Depreciation & amortization: 1916612.1112929622
Net tangible assets: 116965454.75800794
Owner earnings: 20501484.685527235
Return on net tangible assets (%): 17.527811718377144
Capex to operating income (%): 7.567775627693065
Buffett classification: The Great
Stock price: 63.67125685610923
P/E ratio: 30.619897320884476
Shares outstanding: 9625105
Book value: 123643944.35351883
P/B ratio: 4.95651069630876
Market cap (USD): 612842532.7220212
Debt to equity: 0.012419511439650702
Current ratio: 6.360043401234054
Quick ratio: 6.360043401234054
Effective tax rate (%): 26.826555837832476
Interest coverage ratio: 33.642641517290194
COGS to revenue (%): 50.84322818861221
SG&A to revenue (%): 4.419913291872627
Free cash flow (dilution-adjusted): 15071101.239186345
Buyback yield (%): 0
Retained earnings: 108554851.53144726
Receivables turnover: 9.876566934015884
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.473659343868992
FCF margin (%): 25.939239119783934
Revenue growth (%): 9.066481323511061
Rule of 40 score: 35.005720443295
Financial ratios for ICRA.NS — quarterly report dated 2025-06-30
Total revenue: 14566896.793821672
Gross profit: 6409326.000468056
Operating income: 4171940.088930494
Net income: 5003299.789375147
Capital expenditures: 0
Depreciation & amortization: 478832.2021998596
Owner earnings: 5482131.991575006
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 78.50081909665342
P/E ratio: 45.87559564379339
Shares outstanding: 9625105
Market cap (USD): 755578626.3912942
Effective tax rate (%): 26.74388921345735
Interest coverage ratio: 21.644851869839727
COGS to revenue (%): 56.00074544918535
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.521707434207343
Rule of 40 score: -8.521707434207343
Financial ratios for ICRA.NS — quarterly report dated 2025-12-31
Total revenue: 18223359.697003454
Gross profit: 8906516.653670492
Operating income: 5261735.546396347
Net income: 4351208.644313245
Capital expenditures: 0
Depreciation & amortization: 1109379.525453938
Owner earnings: 5460588.169767183
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 67.67851175225577
P/E ratio: 31.285773708386422
Shares outstanding: 9625105
Market cap (USD): 651412781.8591958
Effective tax rate (%): 28.86551377496758
Interest coverage ratio: 48.420912352639675
COGS to revenue (%): 51.12582530467733
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 25.10117944085809
Rule of 40 score: 25.10117944085809
Financial ratios for IMR.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7246376811594204
Shares outstanding: 358542497
Market cap (USD): 259813403.62318844
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMR.AX — annual report dated 2022-12-31
Total revenue: 816011
Gross profit: -1526784
Operating income: -17995085
Net income: -17356267
Capital expenditures: 238859
Depreciation & amortization: 712491
Net tangible assets: 7510440
Owner earnings: -16882635
Return on net tangible assets (%): -224.78889385974722
Buffett classification: The Gruesome
Stock price: 0.25
Shares outstanding: 358542497
Book value: 7510440
P/B ratio: 11.934803320444606
Market cap (USD): 89635624.25
Debt to equity: 0.5978354131049579
Current ratio: 4.6677286481473805
Quick ratio: 3.570364547234398
Interest coverage ratio: -101.14314539925921
COGS to revenue (%): 287.10336012627283
R&D to revenue (%): 973.7771917290331
SG&A to revenue (%): 954.2975523614265
Free cash flow (dilution-adjusted): -16749080
Buyback yield (%): 0.07884476801643962
Retained earnings: -89960984
Inventory turnover: 1.0290116187905267
Receivables turnover: 6.4998008666284335
Capitalized R&D asset: 7946129
ROCI (R&D-adjusted, %): -64.87585417695759
FCF margin (%): -2052.555664078058
Rule of 40 score: -2052.555664078058
Financial ratios for IMR.AX — annual report dated 2023-12-31
Total revenue: 615568
Gross profit: -1115839
Operating income: -17575346
Net income: -22625902
Capital expenditures: 82783
Depreciation & amortization: 707545
Net tangible assets: -8753365
Owner earnings: -22001140
Buffett classification: The Gruesome
Stock price: 0.39041095890410954
Shares outstanding: 358542497
Book value: -8753365
Market cap (USD): 139978920.0616438
Debt to equity: -1.1905151904439035
Current ratio: 0.8624868032135037
Quick ratio: 0.4944425193620362
Interest coverage ratio: -366.55778255156736
COGS to revenue (%): 281.26981909391003
R&D to revenue (%): 1286.5464091700674
SG&A to revenue (%): 1270.3059613235257
Free cash flow (dilution-adjusted): -13060239
Buyback yield (%): 0.06091345751378181
Retained earnings: -112586886
Inventory turnover: 1.0297694596140967
Receivables turnover: 1.5680983908069401
Capitalized R&D asset: 13243474.43
ROCI (R&D-adjusted, %): -87.99358674496474
Rosenberg metric: 0.05171637661558225
FCF margin (%): -2121.656583838016
Revenue growth (%): -24.563762008110185
Rule of 40 score: -2146.2203458461263
Financial ratios for IMR.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -7377033
Buffett classification: The Gruesome
Stock price: 0.84472049689441
Shares outstanding: 358542497
Book value: -7377033
Market cap (USD): 302868196.2236025
Debt to equity: -2.893829944911457
Current ratio: 7.788673435733832
Quick ratio: 7.151108296443884
Buyback yield (%): 0
Retained earnings: -142279717
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IMR.AX — annual report dated 2024-12-31
Total revenue: 959424
Gross profit: -924118
Operating income: -17063657
Net income: -29692831
Capital expenditures: 74976
Depreciation & amortization: 748165
Net tangible assets: -7377033
Owner earnings: -29019642
Buffett classification: The Gruesome
Stock price: 0.84472049689441
Shares outstanding: 358542497
Book value: -7377033
Market cap (USD): 302868196.2236025
Debt to equity: -2.893829944911457
Current ratio: 7.788673435733832
Quick ratio: 7.151108296443884
Interest coverage ratio: -850.4189882880638
COGS to revenue (%): 196.3200837168968
R&D to revenue (%): 852.6140684410647
SG&A to revenue (%): 749.6695934227203
Free cash flow (dilution-adjusted): -15651886
Buyback yield (%): 0.6292826463010031
Retained earnings: -142279717
Inventory turnover: 1.2539825624747012
Receivables turnover: 2.7781851034626546
Capitalized R&D asset: 16108517.13
ROCI (R&D-adjusted, %): -47.76829353765376
Rosenberg metric: 0.024208517434284295
FCF margin (%): -1631.3836218397703
Revenue growth (%): 55.85995373378733
Rule of 40 score: -1575.523668105983
Financial ratios for INTZ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 68.8
Shares outstanding: 22741846
Market cap (USD): 1564639004.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INTZ — annual report dated 2022-12-31
Total revenue: 7529000
Gross profit: 4175000
Operating income: -16283000
Net income: -16229000
Capital expenditures: 307000
Operating cash flow: -13190000
Depreciation & amortization: 1308000
Net tangible assets: -4215000
Owner earnings: -15228000
Buffett classification: The Gruesome
Stock price: 63.2
Shares outstanding: 22741846
Book value: -4215000
Market cap (USD): 1437284667.2
Debt to equity: -2.684697508896797
Current ratio: 0.40923843308928975
Quick ratio: 0.40923843308928975
Interest coverage ratio: -6.902501059771089
COGS to revenue (%): 44.54774870500731
R&D to revenue (%): 85.86797715500066
SG&A to revenue (%): 185.8546951786426
Free cash flow (dilution-adjusted): -16125000
Buyback yield (%): 0
Retained earnings: -96326000
Receivables turnover: 3.977284733227681
Capitalized R&D asset: 6465000
ROCI (R&D-adjusted, %): -480.6503412284223
FCF margin (%): -214.1718687740736
Rule of 40 score: -214.1718687740736
Financial ratios for INTZ — annual report dated 2023-12-31
Total revenue: 5611000
Gross profit: 4354000
Operating income: -12046000
Net income: -13891000
Capital expenditures: 157000
Operating cash flow: -7767000
Depreciation & amortization: 1659000
Net tangible assets: -9555000
Owner earnings: -12389000
Buffett classification: The Gruesome
Stock price: 5
Shares outstanding: 22741846
Book value: -9555000
Market cap (USD): 113709230
Debt to equity: -1.3529042386185244
Current ratio: 0.07979805062758573
Quick ratio: 0.07979805062758573
Interest coverage ratio: -6.380296610169491
COGS to revenue (%): 22.402423810372483
R&D to revenue (%): 99.01978256995187
SG&A to revenue (%): 193.26323293530564
Free cash flow (dilution-adjusted): -10187000
Buyback yield (%): 0
Retained earnings: -110217000
Receivables turnover: 8.399700598802395
Capitalized R&D asset: 9887550
ROCI (R&D-adjusted, %): -559.974393854525
Rosenberg metric: 0.02768754833720031
FCF margin (%): -181.55409018000356
Revenue growth (%): -25.474830654801433
Rule of 40 score: -207.02892083480498
Financial ratios for INTZ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.86
Shares outstanding: 22741846
Market cap (USD): 19557987.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INTZ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.08
Shares outstanding: 22741846
Market cap (USD): 70044885.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INTZ — annual report dated 2024-12-31
Total revenue: 5771000
Gross profit: 4430000
Operating income: -8446000
Net income: -7790000
Capital expenditures: 614000
Operating cash flow: -6293000
Depreciation & amortization: 1648000
Net tangible assets: 6251000
Owner earnings: -6756000
Return on net tangible assets (%): -108.07870740681491
Buffett classification: The Gruesome
Stock price: 3.08
Shares outstanding: 22741846
Book value: 6251000
P/B ratio: 11.205388846584546
Market cap (USD): 70044885.68
Debt to equity: 0.4365701487761958
Current ratio: 1.5070806100217864
Quick ratio: 1.5070806100217864
Interest coverage ratio: -25.75
COGS to revenue (%): 23.23687402529891
R&D to revenue (%): 76.849766071738
SG&A to revenue (%): 146.26581181770922
Free cash flow (dilution-adjusted): -8445000
Buyback yield (%): 0
Retained earnings: -118007000
Receivables turnover: 30.057291666666668
Capitalized R&D asset: 10290970
ROCI (R&D-adjusted, %): -52.384979307298785
Rosenberg metric: 0.013678905687544997
FCF margin (%): -146.33512389533877
Revenue growth (%): 2.851541614685439
Rule of 40 score: -143.48358228065334
Financial ratios for INTZ — quarterly report dated 2025-03-31
Total revenue: 1775000
Gross profit: 1343000
Operating income: -2093000
Net income: -2098000
Capital expenditures: 392000
Operating cash flow: -1690000
Depreciation & amortization: 540000
Net tangible assets: 13401000
Owner earnings: -1950000
Return on net tangible assets (%): -14.551152899037383
Buffett classification: The Gruesome
Stock price: 1.12
Shares outstanding: 22741846
Book value: 13401000
P/B ratio: 1.9006691679725394
Market cap (USD): 25470867.520000003
Debt to equity: 0.1481978956794269
Current ratio: 3.9658456486042692
Quick ratio: 3.9658456486042692
Interest coverage ratio: -72.17241379310344
COGS to revenue (%): 24.338028169014084
R&D to revenue (%): 68.61971830985915
SG&A to revenue (%): 124.95774647887323
Free cash flow (dilution-adjusted): -2699000
Buyback yield (%): 0.31015826193579127
Retained earnings: -120105000
Receivables turnover: 13.653846153846153
Capitalized R&D asset: 1218000
ROCI (R&D-adjusted, %): -7.929433611884866
FCF margin (%): -152.05633802816902
Rule of 40 score: -152.05633802816902
Financial ratios for INTZ — quarterly report dated 2025-06-30
Total revenue: 1873000
Gross profit: 1431000
Operating income: -2086000
Net income: -2042000
Capital expenditures: 333000
Operating cash flow: -1560000
Depreciation & amortization: 391000
Net tangible assets: 11633000
Owner earnings: -1984000
Return on net tangible assets (%): -17.054929940685977
Buffett classification: The Gruesome
Stock price: 2.29
Shares outstanding: 22741846
Book value: 11633000
P/B ratio: 4.476818304822488
Market cap (USD): 52078827.34
Debt to equity: 0.1523252815266913
Current ratio: 3.230058515552818
Quick ratio: 3.230058515552818
Interest coverage ratio: -99.33333333333333
COGS to revenue (%): 23.598505072076883
R&D to revenue (%): 71.11585691404164
SG&A to revenue (%): 116.65776828617192
Free cash flow (dilution-adjusted): -2456000
Buyback yield (%): 0.03456299021958738
Retained earnings: -122147000
Receivables turnover: 1.422171602126044
Capitalized R&D asset: 2148060
ROCI (R&D-adjusted, %): -10.513165708203283
Rosenberg metric: 0.0722495894909688
FCF margin (%): -131.12653497063533
Revenue growth (%): 5.52112676056338
Rule of 40 score: -125.60540821007196
Financial ratios for INTZ — quarterly report dated 2025-09-30
Total revenue: 1966000
Gross profit: 1505000
Operating income: -2136000
Net income: -2094000
Capital expenditures: 34000
Operating cash flow: -2978000
Depreciation & amortization: 425000
Net tangible assets: 9809000
Owner earnings: -1703000
Return on net tangible assets (%): -17.361606687735755
Buffett classification: The Gruesome
Stock price: 1.6
Shares outstanding: 22741846
Book value: 9809000
P/B ratio: 3.7095477214802735
Market cap (USD): 36386953.6
Debt to equity: 0.16260577021103068
Current ratio: 3.109240246406571
Quick ratio: 3.109240246406571
Interest coverage ratio: -125.6470588235294
COGS to revenue (%): 23.448626653102746
R&D to revenue (%): 67.59918616480162
SG&A to revenue (%): 117.59918616480162
Free cash flow (dilution-adjusted): -4062000
Buyback yield (%): 0.08244713291964073
Retained earnings: -124241000
Receivables turnover: 0.8267451640033642
Capitalized R&D asset: 2623380
ROCI (R&D-adjusted, %): -15.151099753397816
Rosenberg metric: 0.05555555555555555
FCF margin (%): -206.61241098677516
Revenue growth (%): 4.965296316070475
Rule of 40 score: -201.6471146707047
Financial ratios for INTZ — annual report dated 2025-12-31
Total revenue: 7095000
Gross profit: 5380000
Operating income: -9164000
Net income: -9059000
Capital expenditures: 777000
Operating cash flow: -6759000
Depreciation & amortization: 1762000
Net tangible assets: 7277000
Owner earnings: -8074000
Return on net tangible assets (%): -110.95231551463516
Buffett classification: The Gruesome
Stock price: 1.15
Shares outstanding: 22741846
Book value: 7277000
P/B ratio: 3.593942957262608
Market cap (USD): 26153122.9
Debt to equity: 0.2415830699464065
Current ratio: 2.3703081232492997
Quick ratio: 2.3703081232492997
Interest coverage ratio: -113.1358024691358
COGS to revenue (%): 24.171952078928825
R&D to revenue (%): 72.89640591966173
SG&A to revenue (%): 132.09302325581396
Free cash flow (dilution-adjusted): -10389000
Buyback yield (%): 0.47413075858715137
Retained earnings: -127066000
Receivables turnover: 52.55555555555556
Capitalized R&D asset: 9976930
ROCI (R&D-adjusted, %): -48.69135807785126
Rosenberg metric: 0.21420518602029312
FCF margin (%): -146.42706131078225
Revenue growth (%): 22.94229769537342
Rule of 40 score: -123.48476361540884
Financial ratios for INTZ — quarterly report dated 2025-12-31
Total revenue: 1481000
Gross profit: 1101000
Operating income: -2849000
Net income: -2825000
Capital expenditures: 18000
Operating cash flow: -531000
Depreciation & amortization: 406000
Net tangible assets: 7277000
Owner earnings: -2437000
Return on net tangible assets (%): -33.4890751683386
Buffett classification: The Gruesome
Stock price: 1.15
Shares outstanding: 22741846
Book value: 7277000
P/B ratio: 3.593942957262608
Market cap (USD): 26153122.9
Debt to equity: 0.2415830699464065
Current ratio: 2.3703081232492997
Quick ratio: 2.3703081232492997
Interest coverage ratio: -203.5
COGS to revenue (%): 25.65833896016205
R&D to revenue (%): 87.30587440918298
SG&A to revenue (%): 179.40580688723836
Free cash flow (dilution-adjusted): -1172000
Buyback yield (%): 0.011470905449689147
Retained earnings: -127066000
Receivables turnover: 10.97037037037037
Capitalized R&D asset: 2622990
ROCI (R&D-adjusted, %): -25.603586283818515
Rosenberg metric: -0.3039879608728367
FCF margin (%): -79.13571910871033
Revenue growth (%): -24.669379450661243
Rule of 40 score: -103.80509855937157
Financial ratios for JGH.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.05072463768115943
Shares outstanding: 2125843687
Market cap (USD): 107832650.7898551
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JGH.AX — annual report dated 2022-12-31
Total revenue: 17391.891891891893
Gross profit: 17391.891891891893
Operating income: -2839527.702702703
Net income: -2503670.2702702703
Capital expenditures: 231841.8918918919
Depreciation & amortization: 218509.45945945947
Net tangible assets: 8797181.756756756
Owner earnings: -2517002.702702703
Return on net tangible assets (%): -28.611466402515735
Buffett classification: The Gruesome
Stock price: 0.033783783783783786
Shares outstanding: 2125843687
Book value: 8521888.513513513
P/B ratio: 8.427597165328235
Market cap (USD): 71819043.47972973
Debt to equity: 0.03947981331063609
Current ratio: 5.31872882064568
Quick ratio: 5.31872882064568
Interest coverage ratio: -148.37244033328628
COGS to revenue (%): 0
SG&A to revenue (%): 10451.647241647239
Free cash flow (dilution-adjusted): -6967854.72972973
Buyback yield (%): 0.5768664965816934
Retained earnings: -7630832.432432433
Receivables turnover: 0.20466580792901104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.75687227714654
FCF margin (%): -40063.81118881118
Rule of 40 score: -40063.81118881118
Financial ratios for JGH.AX — annual report dated 2023-12-31
Operating income: -3379864.383561644
Net income: -3013391.780821918
Capital expenditures: 321604.79452054796
Depreciation & amortization: 388306.16438356164
Net tangible assets: 13572985.616438357
Owner earnings: -2946690.4109589043
Return on net tangible assets (%): -21.70996488340887
Buffett classification: The Gruesome
Stock price: 0.03424657534246576
Shares outstanding: 2125843687
Book value: 13103258.219178082
P/B ratio: 5.556088781536456
Market cap (USD): 72802865.9931507
Debt to equity: 0.09583854941025072
Current ratio: 0.9186108753495201
Quick ratio: 0.9186108753495201
Interest coverage ratio: -278.8383341809346
Free cash flow (dilution-adjusted): -8997097.94520548
Buyback yield (%): 0.1403273447733977
Retained earnings: -10647312.328767123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.664668405763724
Rule of 40 score: 0
Financial ratios for JGH.AX — annual report dated 2024-12-31
Operating income: -3375029.813664596
Net income: -3491990.6832298134
Capital expenditures: 17681.366459627327
Depreciation & amortization: 98494.4099378882
Net tangible assets: 13890981.366459627
Owner earnings: -3411177.639751552
Return on net tangible assets (%): -24.55677932149551
Buffett classification: The Gruesome
Stock price: 0.024844720496894408
Shares outstanding: 2125843687
Book value: 13324220.496894408
P/B ratio: 3.9639086005753783
Market cap (USD): 52815992.22360248
Debt to equity: 0.3774495565563949
Current ratio: 0.4120936249665676
Quick ratio: 0.4120936249665676
Interest coverage ratio: -11.653508621429182
Free cash flow (dilution-adjusted): -6338962.732919254
Buyback yield (%): 0.1487068413981653
Retained earnings: -12999820.49689441
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.283063114622518
Rule of 40 score: 0
Financial ratios for JGH.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 13890981.366459627
Buffett classification: The Gruesome
Stock price: 0.024844720496894408
Shares outstanding: 2125843687
Book value: 13324220.496894408
P/B ratio: 3.9639086005753783
Market cap (USD): 52815992.22360248
Debt to equity: 0.3774495565563949
Current ratio: 0.4120936249665676
Quick ratio: 0.4120936249665676
Buyback yield (%): 0
Retained earnings: -12999820.49689441
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JUBLINGREA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.7192404061717
Shares outstanding: 157716549
Market cap (USD): 902018859.7627589
Buyback yield (%): 0
Retained earnings: 122768429.38151127
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JUBLINGREA.NS — annual report dated 2023-03-31
Total revenue: 577403532.2777102
Gross profit: 248975152.2533496
Operating income: 54092204.62850183
Net income: 37453958.58708892
Capital expenditures: 58242874.54323996
Operating cash flow: 56328989.037758835
Depreciation & amortization: 14882095.006090134
Net tangible assets: 323024360.5359318
Owner earnings: -5906820.950060904
Return on net tangible assets (%): -1.8285992239906794
Capex to operating income (%): 107.67332362074052
Buffett classification: The Gruesome
Stock price: 4.271619975639465
P/E ratio: 17.98755556454209
Shares outstanding: 157716549
Book value: 324754202.19244826
P/B ratio: 2.074507909825552
Market cap (USD): 673705161.1973205
Debt to equity: 0.1525557415858785
Current ratio: 1.541236462285145
Quick ratio: 0.6637068435665389
Effective tax rate (%): 29.58814962721428
Interest coverage ratio: 21.774797744545232
COGS to revenue (%): 56.880216636152895
SG&A to revenue (%): 1.1907436436329377
Free cash flow (dilution-adjusted): -2633130.328867235
Buyback yield (%): 0
Retained earnings: 141008404.3848965
Inventory turnover: 2.604932606326658
Receivables turnover: 9.278908488749003
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.421992762000762
FCF margin (%): -0.45602948054027403
Rule of 40 score: -0.45602948054027403
Financial ratios for JUBLINGREA.NS — annual report dated 2024-03-31
Total revenue: 491719031.05888
Gross profit: 221904784.74637246
Operating income: 35255426.31010912
Net income: 21931646.48039333
Capital expenditures: 67891833.55318384
Operating cash flow: 51562417.55606188
Depreciation & amortization: 16329415.997121956
Net tangible assets: 325823240.19666624
Owner earnings: -29630771.07566855
Return on net tangible assets (%): -9.094124488413865
Capex to operating income (%): 192.57130223303122
Buffett classification: The Gruesome
Stock price: 5.352447216890595
P/E ratio: 38.490931563543036
Shares outstanding: 157716549
Book value: 328273653.9153376
P/B ratio: 2.571542046351219
Market cap (USD): 844169503.7526392
Debt to equity: 0.2704109701133234
Current ratio: 1.3839804179535269
Quick ratio: 0.6520617755093788
Effective tax rate (%): 31.6590125219068
Interest coverage ratio: 5.6533151296054145
COGS to revenue (%): 54.871629786523165
SG&A to revenue (%): 2.2290019741759735
Free cash flow (dilution-adjusted): -17402206.499580283
Buyback yield (%): 0.6092452634796002
Retained earnings: 151182755.72610626
Inventory turnover: 2.390283468766168
Receivables turnover: 7.168998669508313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.531946297739806
FCF margin (%): -3.539054907455166
Revenue growth (%): -14.839621933178456
Rule of 40 score: -18.378676840633624
Financial ratios for JUBLINGREA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 334013377.9264214
Buffett classification: The Gruesome
Stock price: 9.168179646440516
Shares outstanding: 157716549
Book value: 336281653.1294792
P/B ratio: 4.2998886230997915
Market cap (USD): 1445973654.4486382
Debt to equity: 0.2556307386293001
Current ratio: 1.3191405728525447
Quick ratio: 0.659536912054823
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JUBLINGREA.NS — quarterly report dated 2024-12-31
Total revenue: 121932626.18020748
Gross profit: 59147919.33791817
Operating income: 11485021.564284882
Net income: 8087189.649143256
Capital expenditures: 0
Depreciation & amortization: 4634572.794031939
Owner earnings: 12721762.443175195
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.494346660449935
P/E ratio: 46.28973893466417
Shares outstanding: 157716549
Market cap (USD): 1497415590.2958386
Effective tax rate (%): 27.411592383343798
Interest coverage ratio: 7.9523809523809526
COGS to revenue (%): 51.49131024989006
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JUBLINGREA.NS — annual report dated 2025-03-31
Total revenue: 482075052.60696745
Gross profit: 235725976.15150806
Operating income: 42255085.34019172
Net income: 29362871.17138181
Capital expenditures: 41170212.765957445
Operating cash flow: 59397942.48304886
Depreciation & amortization: 18427636.19359364
Net tangible assets: 339477671.2649053
Owner earnings: 6620294.5990180075
Return on net tangible assets (%): 1.9501413964431196
Capex to operating income (%): 97.43256328676165
Buffett classification: The Gruesome
Stock price: 7.532617574979578
P/E ratio: 40.459886975236145
Shares outstanding: 157716549
Book value: 342187982.2305354
P/B ratio: 3.471829843697281
Market cap (USD): 1188018448.8625278
Debt to equity: 0.2609368530232901
Current ratio: 1.3227901273164753
Quick ratio: 0.6494018188475779
Effective tax rate (%): 26.902593056081024
Interest coverage ratio: 6.496225736879943
COGS to revenue (%): 51.101809795643206
SG&A to revenue (%): 1.912665174468374
Free cash flow (dilution-adjusted): 15217442.132335749
Buyback yield (%): 0
Retained earnings: 167455459.43418282
Inventory turnover: 2.2336617501311724
Receivables turnover: 6.792048516632297
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.955194052608153
FCF margin (%): 3.1566541454578085
Revenue growth (%): -1.9612782590791615
Rule of 40 score: 1.195375886378647
Financial ratios for JUBLINGREA.NS — quarterly report dated 2025-03-31
Total revenue: 121365443.06757072
Gross profit: 59062426.93476736
Operating income: 12543839.139583819
Net income: 8656768.76315174
Capital expenditures: 0
Depreciation & amortization: 4604863.221884498
Net tangible assets: 339477671.2649053
Owner earnings: 13261631.985036239
Return on net tangible assets (%): 3.9064813705192893
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.532617574979578
P/E ratio: 34.30894602150595
Shares outstanding: 157716549
Book value: 342187982.2305354
P/B ratio: 3.471829843697281
Market cap (USD): 1188018448.8625278
Debt to equity: 0.2609368530232901
Current ratio: 1.3227901273164753
Quick ratio: 0.6494018188475779
Effective tax rate (%): 27.245038317940658
Interest coverage ratio: 7.7138749101365915
COGS to revenue (%): 51.33505432688603
Buyback yield (%): 0
Retained earnings: 167455459.43418282
Inventory turnover: 0.5649051583873481
Receivables turnover: 1.7099411660067332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9552976119652916
Revenue growth (%): -0.46516107329510387
Rule of 40 score: -0.46516107329510387
Financial ratios for JUBLINGREA.NS — quarterly report dated 2025-06-30
Total revenue: 120456353.84975427
Gross profit: 59674701.61479055
Operating income: 11844137.608237773
Net income: 8787736.95296045
Capital expenditures: 0
Depreciation & amortization: 4778843.903580623
Owner earnings: 13566580.856541073
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.86274280365083
P/E ratio: 54.74768477649069
Shares outstanding: 157716549
Market cap (USD): 1397801209.6663935
Effective tax rate (%): 24.726871805151852
Interest coverage ratio: 7.976359338061466
COGS to revenue (%): 50.45948203842941
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.7490511259537882
Rule of 40 score: -0.7490511259537882
Financial ratios for JUBLINGREA.NS — quarterly report dated 2025-12-31
Total revenue: 115820429.98774646
Gross profit: 53877687.4234154
Operating income: 9079870.780884484
Net income: 5224462.515316921
Capital expenditures: 0
Depreciation & amortization: 5017266.3473320715
Owner earnings: 10241728.862648994
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.806616909880806
P/E ratio: 40.03207042870505
Shares outstanding: 157716549
Market cap (USD): 1231232678.3914447
Effective tax rate (%): 28.298425317229782
Interest coverage ratio: 6.541733547351526
COGS to revenue (%): 53.48170661331897
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.8486337281885685
Rule of 40 score: -3.8486337281885685
Financial ratios for KSL.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.39130434782608703
Shares outstanding: 294332296
Market cap (USD): 115173507.13043481
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KSL.AX — annual report dated 2022-12-31
Total revenue: 247466891.8918919
Net income: 78708108.1081081
Capital expenditures: 9256081.081081081
Depreciation & amortization: 25812837.837837838
Net tangible assets: 328412837.8378378
Owner earnings: 95264864.86486487
Return on net tangible assets (%): 29.007655575237994
Buffett classification: The Gruesome
Stock price: 0.37162162162162166
P/E ratio: 1.3896947565414464
Shares outstanding: 294332296
Book value: 1819057432.4324322
P/B ratio: 0.06013017686246033
Market cap (USD): 109380245.13513514
Debt to equity: 0.01990375918624325
Effective tax rate (%): 21.513563044913692
COGS to revenue (%): 0
SG&A to revenue (%): 47.79618349164917
Free cash flow (dilution-adjusted): 381302702.7027027
Buyback yield (%): 0
Retained earnings: 143333108.1081081
Receivables turnover: 0.16964539230476705
Capitalized R&D asset: 0
FCF margin (%): 154.08230967287463
Rule of 40 score: 154.08230967287463
Financial ratios for KSL.AX — annual report dated 2023-12-31
Total revenue: 275412328.7671233
Net income: 72062328.7671233
Capital expenditures: 8717808.219178082
Depreciation & amortization: 20510958.90410959
Net tangible assets: 356285616.43835616
Owner earnings: 83855479.4520548
Return on net tangible assets (%): 23.536027159985927
Buffett classification: The Gruesome
Stock price: 0.4383561643835617
P/E ratio: 1.7904275165144328
Shares outstanding: 294332296
Book value: 2229605479.4520545
P/B ratio: 0.05786780554579348
Market cap (USD): 129022376.32876714
Debt to equity: 0.010375630064167628
Effective tax rate (%): 39.99292766253543
COGS to revenue (%): 0
SG&A to revenue (%): 46.457615231956076
Free cash flow (dilution-adjusted): 34626712.32876712
Buyback yield (%): 0
Retained earnings: 166508219.1780822
Receivables turnover: 0.15694369960633517
Capitalized R&D asset: 0
FCF margin (%): 12.57268056363808
Revenue growth (%): 11.292596218260824
Rule of 40 score: 23.865276781898906